Met with Radiation Oncologist

[Chasbearcat999]

Met with radiation oncologist today. His recommendation was Cyberknife, no ADT. He did say that if I felt more comfortable with surgery that there was an "amazing" surgeon within 100 miles that he would recommend. I liked the guy, he has been doing Cyberknife for years and felt that with a co-existing condition (Major Depressive Disorder) that ADT while somewhat reducing risk, was best avoided. He spent a lot of time going over the pro's and cons of each treatment. He said that while John's Hopkins did upgrade me to 4+7 (based on 2 cores), there was still a low total volume of 4.

I really didn't feel pushed at all. I told him to start the process.

[Lost_Sheep]

If you don't mind, is that amazing surgeon anywhere near Seattle, Washington? I ask because I am leaning towards surgery and am searching for such a surgeon. The Veteran's Administration is willing to send me to Fred Hutchinson at University of Washington.

Happy for your optimistic outlook and good chances for favorable outcome.

[Chasbearcat999 in reply to Lost_Sheep]

HE is in Cincinnati. Thank you!

[conbio in reply to Lost_Sheep]

A tangent note - I had great treatment with Fred Hutch/UW. Mine was ADT, EBRT, and brachy. If you're going to have PC Seattle is among the best places in the country for treatment.

[cancerfox]

Say hello to Beckey and Heather for me (radiation technicians) if you get your Cyberknife treatments at Norwood! You really lucked out not having to do the ADT.

Best of luck! 🦊

[NotDFL]

You made the right decision.

SBRT/Cyberknife has a long track record by now but there are side effects, I hope you have been fully informed.

[Scorpio53 in reply to NotDFL]

What are th eside effects? Source? Jus wondering since I'm looking at alternatives. Cyberknife came up.

[NotDFL]

Here's a review:

pubmed.ncbi.nlm.nih.gov/309...

Probably more than you wanted to know 😀

But here is the essence of what you were asking:

Estimated late grade ≥3 genitourinary and gastrointestinal toxicity rates were 2.0% (95% CI, 1.4%-2.8%) and 1.1% (95% CI, 0.6%-2.0%), respectively. By 2 years post-SBRT, Expanded Prostate Cancer Index Composite urinary and bowel domain scores returned to baseline.